Exelixis
EXEL
#1554
Rank
NZ$24.66 B
Marketcap
NZ$99.53
Share price
0.57%
Change (1 day)
52.82%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company